Publicly funded cancer trials save more than 3 million years of life
Credit: JAMA Oncology PORTLAND, OR - People diagnosed with cancer gained 3.34 million years of life thanks to cancer clinical trials run by SWOG and...
NEWS INDEX
Effect of treatment trials on survival of patients with cancer in US population
Joseph M. Unger, Ph.D., M.S., of the SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Wash., and coauthors examined how the National...
Time to initiating cancer therapy is increasing, associated with worsening survival
Monday, June 5, 2017, Chicago, Ill.: After reviewing nearly 3.7 million patient records, Cleveland Clinic researchers have shown that newly diagnosed cancer patients are having...
Study: Collateral damage from cosmic rays increases cancer risks for Mars astronauts
The cancer risk for a human mission to Mars has effectively doubled following a UNLV study predicting a dramatic increase in the disease for astronauts...
Black, white men view impacts of prostate cancer treatment differently, study finds
CHICAGO - When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize certain treatment-related factors differently, according...
Targeted therapies show initial effectiveness in subset of papillary thyroid cancer
COLUMBUS, Ohio - Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma also show promise for...
AACR pubs 1st set of screening recs from childhood cancer predisposition workshop
PHILADELPHIA -- The American Association for Cancer Research (AACR) has published its first set of consensus screening recommendations for children with common cancer predisposition syndromes...
Attacking metastatic tumors in the brain
(Bethesda, MD, June 05, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported...
Trends in reoperation after initial lumpectomy for breast cancer
Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative...
Generous health insurance plans encourage overtreatment, but may not improve health
CATONSVILLE, MD, June 5, 2017 - Offering comprehensive health insurance plans with low deductibles and co-pay in exchange for higher annual premiums seems like a...
Research suggests possible new treatment for EGFR-positive lung cancer
ASCO Perspective "It's been nearly 15 years since EGFR-targeted therapies were introduced, helping extend survival for thousands of patients in the time since. The second...
CAR T-Cell therapy sends multiple myeloma into lasting remission
ASCO Perspective "While it's still early, these data are a strong sign that CAR T-cell therapy can send multiple myeloma into remission," said ASCO Expert...
Alectinib halts lung cancer growth more than a year longer than crizotinib
ASCO Perspective "The fact that this second-generation targeted treatment halted advanced lung cancer growth for more than two years while preventing brain metastases is a...
Adding a second HER2 blocker may lower chance of invasive breast cancer for some women
ASCO Perspective "The introduction and success of HER2 targeted treatment was a turning point in breast cancer care. It's promising that some women in this...
Early research suggests first immunotherapy for mesothelioma on the horizon
ASCO Perspective "We're seeing a second wave of immunotherapy with expansion of its use in more cancer types. This study shows that immunotherapy may represent...
